Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / Donors & Friends / Donor Profiles / sanofi-aventis

sanofi-aventis

by Mary Ruth last modified Mar 14, 2011 02:36 PM
sanofi-aventis U.S. made a commitment of $2 million toward the N.C. Cancer Hospital Endowment – which helps support the institution’s clinical research and many patient programs
sanofi-aventis

L-R: sanofi-aventis Chief Executive Officer Chris Veihbacher, Dean William L. Roper, and Physician-in-Chief of the N.C. Cancer Hospital, Richard M. Goldberg

On December 21, 2009, sanofi-aventis Chief Executive Officer Chris Viehbacher and other company leaders announced sanofi-aventis U.S.’s commitment of $2 million toward the N.C. Cancer Hospital Endowment – which helps support the institution’s clinical research and many patient programs.

“This investment in the N.C. Cancer Hospital is a tremendous expression of belief and confidence in our faculty, scientists and staff, and their track record of success in fighting cancer in North Carolina and the nation. This gift will support critical clinical research and program enhancements that will directly benefit cancer patients – both today and for years to come,” said William L. Roper, MD, MPH, Dean of the School of Medicine, Vice Chancellor for Medical Affairs and Chief Executive Officer of the UNC Health Care System.

Read full press release.